SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Wynn Resorts Finance will offer $900M senior unsecured notes due 2035 and use proceeds to redeem its 2027 WLV Notes. The company plans to lend net proceeds to Wynn Las Vegas for th…
The board of directors approved an additional $500 million share repurchase authorization, increasing the total available to $898 million, driven by strong third-quarter fiscal 202…
Alpenhaus Resort sold 2,000 Class B Non-Voting Units to an investor, exchanging them for an Option Agreement. This transaction is a private placement capitalization event relevant …
Williams Companies announced the issuance of $2.75 billion in aggregate principal amount of senior notes maturing in 2029 to 2056. This offering helps the company manage its capita…
Disc Medicine reports its DISC-3405 treatment successfully reduces phlebotomy needs for polycythemia vera patients at the SOHO conference. In its market-perceived most strategic as…
Arrow Financial Corp announced its subsidiary will acquire Skene Valley Agency, expanding insurance operations in Washington County. The deal targets completion by the end of Q3 20…
BKV Corp announced a proposed private offering of up to $460 million in convertible senior notes due 2031. Proceeds will be used for share repurchases and general corporate purpose…
The company, an S&P 400 member, reported portfolio data of 173,559 sites and 453 properties across 35 U.S. states and one Canadian province. Additionally, the filing outlines long-…
Skyx Platforms Corp. announced a completed merger with Deako, Inc., with Skyx becoming a wholly-owned subsidiary. This strategic acquisition is expected to enhance Skyx's market pr…
Joe Manchin has stepped down from the Ramaco Board, citing the need for time on a leadership council. This governance change is a minor event and does not directly impact the compa…
SS Innovations announced global milestones, including new robotic program launches in Colombia and Sri Lanka, while maintaining regulatory progress for U.S. and EU market expansion…
BioCardia announced CEO Peter Altman will present at the H.C. Wainwright Global Investment Conference, covering regulatory progress for CardiAMP and other business developments.
The company reported that combining its drug pelareorep with a RAS inhibitor maintained anticancer activity, supporting clinical investigation to combat therapy resistance.
Candel Therapeutics announced the appointment of Martine Zimmermann to its board of directors. Her addition strengthens the company's leadership ahead of expected regulatory filing…
Turn Therapeutics Inc. announced CEO Bradley Burnam and Executive Clinical Lead Dr. Stephen M. Hahn will present at the Stifel 2026 Virtual Immunology and Inflammation Forum on Sep…
Commerce.com announced a strategic operating plan to boost profitability and free cash flow by targeting 20% non-GAAP operating margins by 2027 and achieving up to $80 million in a…
SCYNEXIS named Sanjay Subramanian as its new CFO, effective September 9, 2026, replacing retiring CFO Ivor Macleod. This leadership change signals a strategic shift as the company …
Cerenome Inc. has filed an EX-4.1 document outlining the terms of a Senior Secured Convertible Note, which raises capital while allowing for future equity conversion.
Zion Oil & Gas filed an exhibit representing a new warrant certificate allowing holders to purchase stock at $0.75 per share expiring in April 2027.
Hanover Bancorp filed an exhibit containing a confidential investor presentation from September 2026, highlighting forward-looking statements and potential risks associated with th…